Home » Health » Romanian Government Approves Compensation for Adult Vaccines: Flu Vaccine Compensated from September 1, Other Vaccines from December 1

Romanian Government Approves Compensation for Adult Vaccines: Flu Vaccine Compensated from September 1, Other Vaccines from December 1

On August 31, the Government of Romania approved a decision regarding vaccines for adults that will benefit from compensation in the country. According to this decision, starting from September 1, the flu vaccine will be compensated, while the other vaccines will be compensated starting from December 1.

This decision was added to Government Decision no. 720/2008, which lists the medicines compensated for those insured under the social health insurance system in Romania, either with personal contribution or without.

This measure follows the proposal of the National Vaccinology Committee to introduce in Romania the vaccination of high-risk groups, with compensation for eight types of vaccines: the flu vaccine, the pneumococcal vaccine, the meningococcal vaccine, the human papilloma virus (HPV) vaccine, the diphtheria vaccine adult acellular tetanus-pertussis (dTPa), hepatitis B vaccine (HBV), measles-mumps-rubella (MMR) vaccine and varicella vaccine.

Vaccines will be administered according to age and identified risk groups, such as pregnant women, people with chronic diseases, medical personnel and others.

The Government Decision created a new category of compensated drugs, sublist E, which includes immunological drugs used for active immunity and prevention of communicable diseases. This sublist has two sections: E1, which covers vaccines compensated at 50% of the reference price, and E2, which provides 100% compensation.

There are three types of vaccines in the E1 section, such as the inactivated flu vaccine and two types of HPV vaccines. 13 positions are included in the E2 section with 100% compensation, covering various vaccines such as influenza, HPV, pneumococcal, meningococcal, diphtheria-tetanus-pertussis, hepatitis B, measles-mumps-rubella and varicella.

The Government Decision will enter into force gradually, starting from September 1, 2023 for the flu vaccine and from December 1, 2023 for the other 7 vaccines. The decision to postpone the compensation of most vaccines was taken for budgetary reasons, and the costs associated with the compensation of vaccines for the year 2023 amount to 116.6 million lei from the budget of the Ministry of Health.

In order to implement this decision, it is necessary to issue an order of the Minister of Health to establish the segments of the population that will benefit from compensation of 100% or 50% of the reference price of vaccines. This order will establish the rules regarding the prescription, issuance and settlement of vaccines for the various categories of the population. The Ministry of Health has already developed a draft order for this purpose, which will regulate these aspects.

According to the project, the population segments that benefit from 50% settlement of the price of vaccines are as follows:

flu vaccination: people aged between 45 and 64 years (inclusive), without chronic diseases.

vaccination against HPV infection: women aged 19 to 45 (inclusive).

The following categories are included for 100% compensation:

flu vaccination: children aged between 6 months and 18 years (inclusive); pregnant; people aged between 19 and 64 years (inclusive) in one of the following situations: chronic cardiovascular diseases, chronic respiratory diseases, chronic kidney diseases, chronic liver diseases, chronic neurological diseases, metabolic diseases, oncological diseases, diseases autoimmune, congenital malformations, obesity, asplenia, people with HIV/AIDS infection, immunosuppressive therapy, congenital immunosuppression transplant, people over 65 years old and medical – sanitary and auxiliary personnel.

vaccination against pneumococcal infection: people aged between 6 and 64 years, in one of the following situations: HIV/AIDS infection, asplenia, sickle cell disease, chronic respiratory diseases, chronic kidney diseases, cochlear implant, immunosuppressive therapy, transplantation, congenital immunosuppression, drainage external ventricular, diabetes, cardiovascular diseases, chronic liver diseases, leukemias, lymphomas, multiple myeloma, people over 65 years old and medical – sanitary and auxiliary personnel.

vaccination against meningococcal infection: people aged between 6 months and 64 years in one of the following situations: HIV/AIDS infection, asplenia, sickle cell disease, oncological diseases, immunosuppressive therapy, transplantation, immunosuppression, persistent deficiencies of complement components, people over 65 years of age years and medical – sanitary personnel.

vaccination against HPV: persons between the ages of 11 and 18 (inclusive).

vaccination against Bordetella pertussis infection: pregnant women, people over 24 years of age, once every 10 years, people with bone marrow transplantation and contacts without a detectable antibody titer (IgG) of people with transplants of organs, tissues or cells of human origin.

vaccination against hepatitis B: dialysis persons not vaccinated before 1995 or chronic dialysis patients who require serologically documented booster doses, persons with HIV/AIDS infection, persons with organ, tissue or cell transplants, persons receiving immunosuppressive therapy, direct contacts of confirmed hepatitis B cases , people with chronic liver diseases, unvaccinated medical staff or with an anti-HBs antibody level of less than 10 IU, after 3 doses of hepatitis B vaccine, social assistance staff in social assistance centers with percutaneous or mucosal risk through exposure to blood fluids, people with asplenia, people in the 19-59 age group with diabetes (for people over 60 the recommendation remains at the discretion of the attending physician), people with hereditary diseases predisposing to liver cirrhosis: Wilson’s disease, alpha- 1 antitrypsin, hemochromatosis.

vaccination against chicken pox: contacts without detectable titer of antibodies (IgG) of persons with transplants of organs, tissues or cells of human origin.

vaccination against measles-mumps-rubella: people with bone marrow transplants and contacts without detectable antibody titer (IgG) of people with organ, tissue or cell transplants.

Source: 360medical.ro

More news on republikanews.ro.

You can find us on the RepublikaNews Facebook page.

2023-09-10 16:07:21
#compensation #vaccines #fits #category #republikaNEWS

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.